04004710 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Assenagon Asset Management S.A. raised its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA – Get Rating) by 46.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 126,106 shares of the biopharmaceutical company’s stock after purchasing an additional 39,878 shares during the quarter. Assenagon Asset Management […]

Peregrine Capital Management LLC boosted its holdings in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA – Get Rating) by 2.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 119,983 shares of the biopharmaceutical company’s stock after buying an additional 3,375 shares during the period. […]

Equities analysts expect Arena Pharmaceuticals, Inc. (NASDAQ:ARNA – Get Rating) to report ($2.32) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Arena Pharmaceuticals’ earnings. The highest EPS estimate is ($2.27) and the lowest is ($2.37). Arena Pharmaceuticals reported earnings of ($1.98) per share during the […]

Cubist Systematic Strategies LLC purchased a new stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA – Get Rating) in the 3rd quarter, HoldingsChannel.com reports. The fund purchased 12,315 shares of the biopharmaceutical company’s stock, valued at approximately $733,000. Other institutional investors have also recently bought and sold shares of the company. Man Group plc acquired a new […]